Reversing effect of exogenous WWOX gene expression on malignant phenotype of primary cultured lung carcinoma cells

Chinese Medical Journal

Volumn 123, Issue 5, 2010, Pages 615-620

  Zhou, Yu Long ^a   Li, Yue Chuan ^a   Shou, Feng ^a   Liu, Chang Qi ^a   Pu, Yong ^b   Tang, Hua ^b  

^a TIANJIN CHEST HOSPITAL   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Primary cultured lung carcinoma cells; Transfection; WWOX gene

Indexed keywords

OXIDOREDUCTASE; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TRANSPLANTATION; CARCINOMA CELL; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; LUNG CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING; WWOX GENE;

ANIMALS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; OXIDOREDUCTASES; PHENOTYPE; TUMOR SUPPRESSOR PROTEINS;

EID: 77949351023     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.05.020     Document Type: Article

References (21)

1. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM, et al. WWOX, a novel WW domain containing protein mapping to human chromosome 1 6q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 2000; 60: 2140-2145.
2. Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, et al. Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res 2000; 60: 1683-1689.
3. Ramos D, Aldaz CM. WWOX, a chromosomal fragile site gene and its role in cancer. Adv Exp Med Biol 2006; 587: 149-159.
4. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, et al. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cell. Hum Mol Genet 2000; 9: 651-663.
5. O'Keefe LV, Richards RI. Common chromosomal fragile sites and cancer: focus on FRA16D. Cancer Lett 2006; 232: 37-47.
6. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, et al. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A 2001; 98: 11417-11422.
7. Nunez MI, Ludes-Meyers J, Aldaz CM. WWOX protein expression in normal human tissues. J Mol Histol 2006; 37: 115-125.
8. Wang TT, Eldo EF, Ma R, Hu SY, Liu CZ, Zhang GY, et al. Expression of FHIT mRNA and WWOX mRNA in human breast cancer and their clinical significance. Chin J Gener Surg (Chin) 2005; 14: 687-690.
9. Płuciennik E, Kusińska R, Potemski P, Kubiak R, Kordek R, Bednarek AK. WWOX-the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Eur J Surg Oncol 2006; 32: 153-157.
10. Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, et al. The fragile genes FHIT and WWOX are inactivated co-ordinately in invasive breast carcinoma. Cancer 2004; 100: 1605-1614.
11. Nunez MI, Rosen DG, Ludes-Meyers JH, Abba MC, Kil H, Page R, et al. WWOX protein expression varies among ovarian carcinoma isotypes and correlates with less favourable outcome. BMC Cancer 2005; 5: 64.
12. Gourley C, Paige AJ, Taylor KJ, Scott D, Francis NJ, Rush R, et al. WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear. Int J Oncol 2005; 26: 1681-1689.
13. Aqeilan RI, Kuroki T, Pekarsky Y, Albagha O, Trapasso F, Baffa R, et al. Loss of WWOX expression in gastric carcinoma. Clin Can Res 2004; 10: 3053-3058.
14. Ramos D, Abba M, López-Guerrero JA, Rubio J, Solsona E, Almenar S, et al. Low levels of WWOX protein immunoexpression correlate with tumor grade and a less favorable outcome in patients with urinary bladder tumours. Histopathology 2008; 52: 831-839.
15. Aqeilan RI, Hagan JP, Aqeilan HA, Pichiorri F, Fong LY, Croce CM. Inactivation of the WWOX gene accelerates forestomach tumor progression in vivo. Cancer Res 2007; 67: 5606-5610.
16. Cantor JP, Iliopoulos D, Rao AS, Druck T, Semba S, Han SY, et al. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer 2007; 120: 24-31.
17. Nakayama S, Semba S, Maeda N, Aqeilan RI, Huebner K, Yokozaki H. Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells. Cancer Sci 2008; 99: 1370-1376.
18. Qin HR, Iliopoulos D, Semba S, Fabbri M, Druck T, Volinia S, et al. A role for the WWOX gene in prostate cancer. Cancer Res 2006; 66: 6477-6481.
19. Chang NS, Pratt N, Heath J, Schultz L, Sleve D, Carey GB, et al. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem 2001; 276: 3361-3370.
20. Aqeilan RI, Pekarsky Y, Herrero JJ, Palamarchuk A, Letofsky J, Druck T, et al. Functional association between WWOX tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci USA 2004; 101: 4401-4406.
21. Watanabe A, Hippo Y, Taniguchi H, Iwanari H, Yashiro M, Hirakawa K, et a1. An opposing view on WWOX protein function as a tumor suppressor. Cancer Res 2003; 63: 8629-8633.